Inventor
LECHUGA-BALLESTEROS DAVID
US24 patents
⚠️ This page may combine multiple inventors who share the name “LECHUGA-BALLESTEROS DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NEKTAR THERAPEUTICS
4 patentsUS7482024B2Jan 27, 2009
Compositions comprising an active agent
NEKTAR THERAPEUTICS32 citations96
US6835372B2Dec 28, 2004
Compositions comprising an active agent
NEKTAR THERAPEUTICS53 citations96
US7326691B2Feb 5, 2008
Compositions comprising amphotericin B, methods, and systems
NEKTAR THERAPEUTICS14 citations78
US11129794B2Sep 28, 2021
Chemically modified small molecules
NEKTAR THERAPEUTICS1 citations71
VEHRING REINHARD
3 patentsUS8815258B2Aug 26, 2014
Compositions, methods and systems for respiratory delivery of two or more active agents
VEHRING REINHARD9 citations82
US8324266B2Dec 4, 2012
Compositions, methods and systems for respiratory delivery of two or more active agents
VEHRING REINHARD11 citations82
US8668934B2Mar 11, 2014
Pharmaceutical formulation comprising a water-insoluble active agent
VEHRING REINHARD11 citations81
PEARL THERAPEUTICS INC
3 patentsUS8703806B2Apr 22, 2014
Compositions, methods and propellant-based systems for respiratory delivery of glycopyrrolate and one or more active agents
PEARL THERAPEUTICS INC6 citations79
US9415009B2Aug 16, 2016
Compositions, methods and systems for respiratory delivery of two or more active agents
PEARL THERAPEUTICS INC1 citations60
US11471468B2Oct 18, 2022
Methods and systems for conditioning of particulate crystalline materials
PEARL THERAPEUTICS INC0 citations44
INHALE THERAPEUTIC SYST
2 patentsABBOTT LAB
2 patentsOHTAKE SATOSHI
2 patentsMEDIMMUNE LTD
2 patentsUS12178911B2Dec 31, 2024
Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereof
MEDIMMUNE LTD0 citations51
US11904053B2Feb 20, 2024
Dry powder formulations of thymic stromal lymphopoietin (TSLP)-binding antibodies and methods of use thereof
MEDIMMUNE LTD0 citations51